Racial and ethnic minorities, older adults, rural residents, and individuals of low
socioeconomic status are underrepresented among participants in cancer‐related trials. The …

OBJECTIVE: This systematic review was conducted to synthesize the existing evidence
regarding key considerations influencing African Americans' participation in cancer clinical …

Older adults continue to be underrepresented in clinical research despite their burgeoning
population in the United States and worldwide. Physicians often propose treatment plans for …

Low participation of Black Americans in cancer clinical trials is a well-established
predicament. Many factors resulted in this current dilemma with racism being the …

Clinical trials help advance public health and medical research on prevention, diagnosis,
screening, treatment, and quality of life. Despite the need for access to quality care in …

Background Minority populations in the United States, especially blacks and Hispanics, are
generally underrepresented among participants in clinical trials. Here, we report the …

Abstract Background Despite multiple efforts, African American women continue to be
inadequately represented in clinical research while being overrepresented in disease …

Abstract While African Americans are at a significantly higher risk for developing certain
cancers, they also have low rates of participation in cancer research, particularly clinical …

Radiation oncology clinical trials lack full representation of the ethnic and racial diversity
present in the general United States and in the cancer patient population. There are low …

Lung carcinoma is the most commonly diagnosed cancer and the leading cause of cancer
deaths in the US. It accounts for 12% of all cancers diagnosed worldwide, making it the most …